ESMO President: What to watch for at ESMO 2021
ESMO President: What to watch for at ESMO 2021
Oesophageal and gastric cancers
BEACON-CRC: first-line bevacizumab in colorectal cancer treatment
OncoAlert and ecancer weekly round up for July 12- July 18, 2021
Cell free DNA BRAF mutant allele fraction and whole exome sequencing in BRAFV600E metastatic colorectal cancer
OncoAlert and ecancer weekly round up for July 1- July 10, 2021
Study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic oesophageal cancer
Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction cancer
Pembrolizumab improves on chemo in MSI-H/dMMR mCRC
CHRONOS: Anti-EGFR rechallenge therapy with panitumumab driven by ctDNA molecular selection in mCC
Tislelizumab in oesophageal cancer after systemic therapy
OncoAlert and ecancer ASCO roundup - Day 3